This page includes the latest FDA filings for Agile Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | AGRX | DUNS 102678187 |
Device Company | Device | Date |
|---|---|---|
| Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2024-07-12 |
| Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2023-11-18 |
| Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2022-05-13 |
| Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2021-12-08 |
| Agile Therapeutics, Inc., Bayer AG, Corium International, Inc., Eurofins Lancaster Laboratories, Inc, SGS North America Inc., TPM Laboratories, Inc., Pace Analytical Life Sciences | Prescription Medication | 2020-09-12 |
| Agile Therapeutics, Inc. | Twirla | 2020-09-11 |
| NCAGE Code | 8QBG9 | AGILE THERAPEUTICS, INC. |
| SEC | 0001261249 | AGILE THERAPEUTICS INC of DELAWARE |